Antiplatelet agent indobufen was noninferior to aspirin in combination with clopidogrel after coronary intervention on both efficacy and safety outcomes, with less mostly minor bleeding.
A sham-controlled trial in this progressive, often debilitating disease showed patients treated with a radiofrequency device had longer 6-minute walk times and other benefits.
Patients with heart failure on sacubitril/valsartan had no signal of cognitive decline compared with controls in PERSPECTIVE, a prospective, multicenter study.
Another Agent Raises Hopes for Obstructive HCM in Early Study medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.